Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0051 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-661 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
filingDate |
2015-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2017-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2017516815-A |
titleOfInvention |
Treatment of familial exudative vitreoretinopathy by inhibition of S1PR2 |
abstract |
Methods and compositions for treating familial exudative vitreoretinopathy (FEVR) and retinopathy of prematurity (ROP) by administering a therapeutically effective amount of a sphingosine-1-phosphate receptor type 2 (S1PR2) inhibitor Things are provided. In one aspect, administering a pharmaceutical composition comprising a therapeutically effective amount of an S1PR2 inhibitor, an amount of at least one buffer sufficient to reduce degradation of the S1PR2 inhibitor, to reduce retinal vascular disorders in a patient. A method of treating is provided. |
priorityDate |
2014-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |